| Print
Novo Nordisk A/S (NOVO B)
Open
259.70 DKK
Previous close
257.00 DKK
Trade high
259.70 DKK
Volume
10
Year high
406.80 DKK
Year low
228.65 DKK
Dividend yield
4.55%
Market capitalisation
1.15 tn DKK
P/E ratio
9.81
ISIN
DK0062498333
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Share price
Company profile
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Recent trades
| Date | Time | Price | Quantity | Value |
|---|---|---|---|---|
| 15/10/2026 | 02:43:10 | 259.7 | 10 | 2,597.00 |
| 13/10/2026 | 02:47:59 | 257 | 10 | 2,570.00 |
| 12/10/2026 | 02:49:58 | 256.45 | 265 | 67,959.25 |
| 05/10/2026 | 02:36:48 | 247.3 | 10 | 2,473.00 |
| 02/10/2026 | 02:57:04 | 248 | 10 | 2,480.00 |